A Biopsychosocial Assessment Template is a structured clinical evaluation framework that captures the complete multidimensional picture of a patient across biological, psychological, and social domains to support psychiatric diagnosis, treatment planning, and care coordination.
The biopsychosocial model recognizes that mental health conditions do not arise from a single cause. Biological vulnerabilities, psychological patterns, and social stressors interact to produce the clinical presentation the clinician encounters. A structured assessment template ensures all three domains are systematically evaluated, documented, and integrated into a coherent clinical formulation that drives the treatment plan.
Biopsychosocial Assessment Template cases involve:
Generic Biopsychosocial Assessment templates fail because they:
Identifying Information: Name, DOB, Age, Gender, Referral source, Date of assessment
Presenting Problem: Chief complaint, Symptom description, Onset, Duration, Severity, Functional impact
Biological Domain: Medical history, Current medications, Allergies, Neurological history, Genetic and family medical history, Sleep, appetite, and physical health status
Psychiatric History: Prior diagnoses, Hospitalizations, Outpatient treatment history, Medication trials and responses, Suicide and self-harm history
Substance Use History: Substances used, Age of onset, Frequency, Quantity, Last use, Treatment history, CAGE or AUDIT screening score
Developmental History: Prenatal and birth history, Developmental milestones, Educational history, Trauma and adverse childhood experiences
Psychological Domain: Mental status examination, Cognitive functioning, Emotional regulation, Coping strategies, Personality features, Trauma responses
Social Domain: Family history and relationships, Social support network, Housing and financial stability, Employment and occupational functioning, Legal history, Cultural identity and background
Strengths and Protective Factors: Personal resilience factors, Social supports, Skills and resources
Clinical Formulation: Integration of biological, psychological, and social factors explaining the current presentation
Diagnosis: DSM-5 diagnoses with clinical rationale
Treatment Recommendations: Level of care, Modality, Goals, Referrals
Fictional, illustrative sample for educational/reference purposes only, does not represent a real patient.
Identifying Information:
Presenting Problem: Chief complaint (patient's words): "I can't sleep, I'm irritable all the time, and I've lost interest in almost everything. I don't think I can keep going like this." Symptom description: depressed mood, anhedonia, insomnia (early morning waking), poor concentration, low energy, irritability, passive thoughts of "not wanting to be here" without plan or intent. Onset: gradual over 4 months, worsening in the last 3 weeks. Duration: persistent daily symptoms for ~5 weeks. Severity: moderate–severe (PHQ-9 = 19). Functional impact: 6 missed workdays in past month, social withdrawal, rising marital conflict.
Biological Domain: Medical history: Type 2 diabetes (2021, diet-controlled), hypertension (well controlled). Current medications: Metformin 500mg BID, Lisinopril 10mg daily. Allergies: NKDA. Neurological history: no seizures, head trauma, or LOC. Genetic/family medical history: mother, major depressive disorder (SSRI-treated); father, hypertension, T2DM; maternal uncle, died by suicide. Sleep/appetite/physical health: sleep reduced to 4–5 hrs with early waking, decreased appetite with 8-lb weight loss over 6 weeks, fatigue, low activity.
Psychiatric History: Prior diagnoses: Generalized Anxiety Disorder (2018, by PCP). Hospitalizations: none. Outpatient treatment history: 6 sessions of CBT in 2019, partial benefit, discontinued due to scheduling. Medication trials/response: Sertraline 50mg (2018–2019), moderate improvement, discontinued after symptom resolution. Suicide/self-harm history: denies prior attempts or self-harm; reports passive SI over past 2 weeks, denies intent/plan/means; identifies spouse and children as protective factors. No current safety plan, priority for this visit.
Substance Use History: Alcohol, onset age 19, 2–3x/week, 3–4 drinks/occasion, last use 3 days ago, no prior treatment, CAGE score 1/4. Nicotine (vaping), onset age 22, daily, ~1 pod/day, used today. Cannabis and other illicit substances,denied. Clinical note: subthreshold for use disorder; alcohol likely worsening sleep/mood and warrants psychoeducation.
Developmental History: Prenatal/birth: full-term, no reported complications (per patient; mother deceased, limited collateral). Developmental milestones: met on time per recollection. Educational history: bachelor's degree in accounting, average performance, no learning disability. Trauma/ACEs: parents' divorce at age 9, witnessed verbal conflict; denies physical/sexual abuse. ACE score: 2 (parental divorce, household mental illness).
Psychological Domain: Mental status exam: alert/oriented x4, disheveled appearance, poor eye contact, mood "hopeless," affect constricted/congruent, speech slow/soft, thought process linear, no psychosis, passive SI present, insight fair, judgment intact. Cognitive functioning: grossly intact, mild subjective concentration difficulty. Emotional regulation: increased irritability, "snapping" at family. Coping strategies: historically exercise and social connection, both declined; uses alcohol to "wind down." Personality features: lifelong perfectionism, self-criticism, reluctance to ask for help. Trauma responses: no acute trauma symptoms; childhood divorce appears linked to current conflict avoidance and help-seeking reluctance.
Social Domain: Family history/relationships: married 6 years, two children (ages 3, 5), increasing marital tension tied to his withdrawal/irritability, spouse supportive but "worn out." Social support network: limited,1–2 close friends, contact declining over 4 months. Housing/financial stability: stable housing (owns home), financial stress from reduced work hours. Employment/occupational functioning: staff accountant, 5 years, performance declining, recent written warning. Legal history: none. Cultural identity/background: Mexican-American, second generation; cultural expectation of self-reliance and mental health stigma described as a barrier to earlier help-seeking.
Strengths and Protective Factors: Self-initiated presentation for care, strong bond with spouse and children, prior positive response to therapy/medication, steady employment history, good insight and willingness to engage in self-reflection.
Clinical Formulation: Jordan presents with a moderate-to-severe major depressive episode arising from biological vulnerability (family history of depression and suicide, chronic illness contributing to fatigue), psychological predisposition (perfectionism, learned self-reliance from childhood family disruption, prior partial treatment response suggesting biological responsiveness), and social precipitants (work pressure, financial strain, eroding marital/social support). Alcohol use functions as a maladaptive coping strategy worsening sleep and mood. Cultural stigma has delayed help-seeking. Protective factors, insight, family attachment, prior treatment response, suggest favorable prognosis with prompt intervention, particularly given the passive SI requiring immediate safety planning.
Diagnosis: Major Depressive Disorder, Single Episode, Moderate to Severe (DSM-5 F33.1), rationale: 5+ weeks depressed mood, anhedonia, sleep/appetite disturbance, low energy, passive SI, functional impairment. Generalized Anxiety Disorder, in partial remission, relevant to case history though currently subthreshold. Rule out: Alcohol Use, mild, subthreshold per CAGE, continue monitoring.
Treatment Recommendations: Level of care: outpatient, safety plan completed this session given passive SI, no indication for higher level of care given absence of intent/plan and strong protective factors. Modality: individual CBT with behavioral activation; psychiatric medication evaluation (SSRI trial given prior partial response). Goals: reduce PHQ-9 to <10 within 8–12 weeks; establish/maintain safety plan; reduce alcohol as coping strategy; improve marital communication and re-engage social supports. Referrals: psychiatric medication evaluation, optional couples counseling, culturally-informed therapist given stigma concerns. Follow-up: weekly therapy, psychiatry follow-up within 2 weeks, safety check-in call in 3–5 days.
The template gives you the structure. When you start using it with Marvix AI, the documentation itself adapts to how you write. Marvix AI uses neural style transfer to learn from your existing notes, so you have custom made templates for all your workflows. It picks up your tone, your phrasing, and structure, then carries that into every note it generates.
Generic behavioral health intake forms document each domain as a parallel checklist without producing an integrated clinical formulation. AI scribes transcribe the intake interview but do not structure the three-domain integration or produce the formulation. Marvix AI generates biopsychosocial assessments that integrate all three domains into a coherent clinical formulation in the clinician's own documentation style.
| Feature | Generic Templates | AI Scribes | Marvix AI |
|---|---|---|---|
| Three-domain integration | Parallel checklists | No | Yes |
| Trauma and developmental history | Basic | Variable | Comprehensive |
| Cultural formulation | Missing | No | Yes |
| Strengths documentation | Missing | No | Yes |
| Integrated clinical formulation | Missing | No | Yes |
This template standardizes psychiatric evaluation by capturing appearance, behavior, speech, mood, affect, thought process, cognition, insight, judgment, and risk assessment in a structured format used during intake, follow-ups, and emergency evaluations.
Link to the template
This template documents Data, Assessment, and Plan sections for behavioral health, counseling, and psychotherapy encounters, giving clinicians a structured alternative to SOAP for ongoing therapy documentation.
Link to the template
This resource compares the three most common behavioral health note formats, helping clinicians choose the structure that best fits their documentation style and payer requirements.
Link to the template
This template is built for EMDR therapy sessions, with structured sections for target memory components, SUDs and VoC scores, bilateral stimulation, processing observations, body scan, closure, and next-session planning across all eight EMDR phases.
Link to the template
This template structures the clinical encounter into Subjective, Objective, Assessment, and Plan, and is commonly adapted for psychiatric and behavioral health visits alongside biopsychosocial intake documentation.
Link to the template
A biopsychosocial assessment provides a comprehensive multidimensional evaluation of a patient across biological, psychological, and social domains to support psychiatric diagnosis, treatment planning, and level-of-care determination. It captures the full context of the patient's presentation including medical history, psychiatric history, trauma, substance use, developmental background, social functioning, and cultural factors, then integrates these into a clinical formulation.
The biological domain covers medical history, medications, neurological factors, genetic vulnerability, and physical health status. The psychological domain covers psychiatric history, mental status, cognitive functioning, emotional regulation, coping patterns, trauma responses, and personality features. The social domain covers family history, social support network, housing, employment, legal history, cultural identity, and social determinants of health. All three are integrated in the clinical formulation.
A psychiatric evaluation focuses primarily on psychiatric symptoms, diagnosis, and medication management with a medical model framework. A biopsychosocial assessment explicitly evaluates all three domains and produces an integrated clinical formulation that explains the patient's presentation in terms of biological vulnerabilities, psychological patterns, and social stressors. It is broader in scope and produces a formulation that drives psychotherapy and social intervention planning alongside pharmacotherapy.
A free biopsychosocial assessment template PDF is available for download on this page along with a completed sample. The template covers all three assessment domains with structured fields for presenting problem, psychiatric and medical history, substance use, developmental and trauma history, mental status examination, social functioning, cultural formulation, strengths, integrated clinical formulation, diagnosis, and treatment recommendations.
A clinical formulation is the integrative section of the biopsychosocial assessment where the clinician synthesizes findings from all three domains to explain why this patient is presenting with this problem at this time. It answers the predisposing, precipitating, perpetuating, and protective factors question and provides the conceptual framework that guides individualized treatment planning beyond diagnosis alone.
Marvix AI generates biopsychosocial assessments that capture all three domains comprehensively, document trauma and developmental history with clinical relevance, include cultural formulation and strengths sections, and produce an integrated clinical formulation in the clinician's own documentation style. It reduces the time required for initial intake documentation while ensuring the depth required for accreditation, authorization, and treatment planning.
General Medical DisclaimerThis content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment.
Clinical Responsibility DisclaimerUse of this template does not replace independent clinical decision-making. The clinician remains fully responsible for all documented information.
No Patient Relationship DisclaimerThis content does not establish a clinician–patient relationship. It is intended solely as a documentation reference for healthcare professionals.
Template Use DisclaimerTemplates are structural guides and may require modification based on specialty, patient context, and institutional requirements.
Regulatory Compliance DisclaimerUsers are responsible for ensuring documentation complies with local laws, licensing requirements, payer guidelines, and institutional policies.
Billing and Coding DisclaimerTemplates are not a substitute for proper coding knowledge. Clinicians must ensure documentation meets E/M coding and reimbursement standards.
Data Privacy DisclaimerPatient information must comply with applicable data protection regulations such as HIPAA or other regional privacy laws.
No Guarantee of Outcomes DisclaimerUse of these templates does not guarantee clinical outcomes, documentation acceptance, or reimbursement approval.
Third-Party Tools Disclaimer (Marvix AI)When using AI-assisted documentation tools such as Marvix AI, clinicians should review all generated content for accuracy before finalizing records.
Jurisdictional Variation DisclaimerClinical documentation standards and legal requirements vary by country, state, and institution.
Educational Use DisclaimerThese templates may be used for training or academic purposes but should be validated before use in real clinical environments.
Limitation of Liability DisclaimerThe creators of this content are not liable for any errors, omissions, or outcomes resulting from the use of these templates.
© 2026 Marvix AI . All Rights Reserved
@2026 Marvix AI . All Rights Reserved
.png)
